Coherus Oncology, Inc. (CHRS) stock
CHRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3059% below fair value
$0.48−0.03 (-5.42%)
Close on Nov 17, 2026Market cap $73.93MP/E –Yield –
Coherus Oncology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Coherus Oncology's market cap was $89.98M on Nov 11, 2026, against $158.08M a year earlier. Over the last 5 years it ranged from $84.76M to $1.22B, with a median of $232.41M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $89.98M | -45.5% |
| 2025 | Dec 31, 2025 | $165.06M | +3.8% |
| 2024 | Dec 31, 2024 | $158.99M | -56.2% |
| 2023 | Dec 29, 2023 | $363.35M | -41.0% |
| 2022 | Dec 30, 2022 | $615.94M | -49.6% |
| 2021 | Dec 31, 2021 | $1.22B | -13.4% |
| 2020 | Dec 31, 2020 | $1.41B | +5.7% |
| 2019 | Dec 31, 2019 | $1.33B | +135.7% |
| 2018 | Dec 31, 2018 | $566.38M | +29.7% |
| 2017 | Dec 29, 2017 | $436.55M | -63.6% |
| 2016 | Dec 30, 2016 | $1.20B | +57.0% |
| 2015 | Dec 31, 2015 | $763.60M | +911.8% |
| 2014 | Dec 31, 2014 | $75.47M | – |
See a number that looks wrong?